Insulet

Company profile

About Insulet

Insulet Corporation (NASDAQ: PODD) is an innovative medical device company founded in 2000 that transforms the lives of people with diabetes through its revolutionary Omnipod insulin delivery system. Born from a father's determination to free his son from the burden of multiple daily insulin injections, Insulet has grown into a global leader in diabetes management technology. The company's flagship product line features tubeless, wearable, waterproof Pod-based insulin management systems that provide continuous insulin delivery without the constraints of traditional tubed pumps. Headquartered in Acton, Massachusetts, with manufacturing facilities and offices around the world, Insulet serves over 600,000 customers across 25 countries in North America, Europe, the Middle East, and Asia Pacific. The company's Omnipod 5 Automated Insulin Delivery System represents a breakthrough in diabetes care as the first truly wearable, automated insulin delivery system controlled by a smartphone. With $2.7 billion in 2025 revenue and recognition as the #1 U.S. requested and prescribed automated insulin delivery (AID) system, Insulet continues to advance its mission of creating a world where diabetes demands less every day, everywhere. The company maintains a strong commitment to quality, safety, and sustainability while continuously innovating to improve outcomes for the diabetes community.

Company description · Insulet official website

Mission. Born of empathy, driven by ingenuity, proven by science, we transform the lives of people with diabetes. We envision a world where diabetes demands less every day, everywhere.